Smokefreenurses.org.nz
SMOKING CESSATION
BEYOND THE ABC:
Tailoring strategies to high-risk groups
36 BPJ Issue 64
Smoking rates are declining in New Zealand as more and more people are successfully quitting. However,
rates remain unacceptably high among deprived communities, Māori and Pacific peoples and in people with mental health disorders. It is often helpful to think of smoking as a chronic relapsing disease, thereby acknowledging the difficulties of smoking cessation and the likelihood of relapse. Ideally, health professionals should be providing smoking cessation support in the ABC format to every patient who
smokes, at every consultation. It is also important to individualise cessation support by understanding why
a patient's previous quit attempts have failed and encouraging a wave of social support for future attempts, particularly in groups with high rates of smoking. Health professionals who are able to do this increase the chances that patients will be able to stop smoking long-term.
Identifying groups with high rates of
number of people who attempt to stop smoking by 40 – 60%.4
This means that one extra person can be expected to attempt
to give up smoking for every seven people who are advised to
In New Zealand, smoking rates are falling; daily smoking
do so and offered support in their attempt.4
among all adults was 18.3% in 2006/07, 16.4% in 2011/12 and most recently, 15.5% in 2012/13.1 However, smoking is
Tailoring support to patients by understanding their quit-
analogous to a chronic disease with frequent relapses, and
history and circumstances means that health professionals can
ongoing work is required to continue this downward trend in
increase the chances of the patient's next attempt succeeding.
the number of people who smoke.
It is important to let patients who are quitting know that it is likely that they will lapse. However, behavioural support, e.g.
Smoking rates are substantially higher than the national
Quitline, and pharmacological smoking cessation aids, do help
average, and particularly concerning in:
prevent a lapse in abstinence becoming a return to regular
People who live in highly deprived areas
Māori and Pacific peoples
Current smoking is associated with poverty
People with mental health disorders
Deprivation is strongly associated with smoking in New
Zealand (Figure 1, over page). After adjusting for age, sex and
The good news is that many people who smoke also frequently
ethnicity, a person from one of the most deprived communities
think about quitting, regardless of their background. When
in New Zealand (Decile 10) is over three time more likely to
surveyed, approximately 40% of people who smoke reported
be a current smoker, compared with a person from one of
attempting to quit in the previous 12 months.2 However, most
the least deprived communities (Decile 1).1 Women who live
attempts to quit do not succeed, and long-term success, e.g.
in lower socioeconomic areas are also more likely to smoke
remaining smokefree for at least six months, is only achieved
during pregnancy (17%) compared with pregnant women in
in 3 – 5% of attempts without the support of a health
the general population (11%).5
Smoking rates in Māori and Pacific peoples must be
There are two strategies that health professionals can pursue
in order to increase the number of people who quit smoking
Almost one-third (32.7%) of Māori smoke, a rate more than twice
as high as New Zealanders of European descent, and more
1. Increase the number of people who attempt to quit
than one-third of Māori women smoke during pregnancy.5, 7
Death rates due to lung cancer and smoking-related diseases
2. Increase the success rate of quit attempts
are three times higher in Māori than non-Māori.7 However, it is encouraging to know that most Māori who smoke do want
Brief advice to stop smoking and, most importantly, an offer
to quit. During the five-year period between 2006 and 2011,
of cessation support by a health professional can increase the
it was estimated that almost two-thirds (62%) of Māori who
BPJ Issue 64 37
smoked made at least one quit attempt.7 It is important that
reported that 32% of Tokelauan and 30% of Cook Island people
these previously unsuccessful attempts be acknowledged and
were classified as regular smokers in the 2013/14 New Zealand
lessons learnt when future attempts to quit smoking are made.
census, while 13% of people who identified as Fijian were
It is also good news that the number of Māori youth who have
regular smokers.9 Encouragingly, rates of smoking are reported
never smoked is increasing: for boys from 58% in 2006/07 to
to be declining among Pacific youth. Regular smoking among
75% in 2013/14, and for girls from 52% in 2006/07 to 72% in
Pacific boys aged 15 – 19 years dropped to 13.6% in 2013/14
2013/14.7 Relative to their population size, Māori also tend to
(from 20.1% in 2006/07), and regular smoking among Pacific
use smoking cessation support services more than non-Māori;
girls of the same age fel to 10.3% in 2013/14 (from 21.4% in
from April to June 2014 Māori accounted for almost one in five
Quitline caller registrations.8
Māori who do not smoke are exposed to second-hand smoke
Smoking prevalence increases with severity of mental
more (11.4%) than non-Māori who do not smoke (6.4%).7 This
increases the severity of the negative health effects of smoking
People with a mental health disorder are approximately twice
on Māori children. More than 20% of Māori households with
as likely to smoke as people who do not have a mental health
one or more child have at least one person who smokes inside
disorder and generally, the level of nicotine dependence
the home, compared to under 8% in non-Māori households.7
increases with the severity of the illness.10 Many people with mental health disorders who smoke will require additional
The overall rate of smoking among Pacific peoples is 23%,
support from health professionals to achieve long-term
although this varies greatly depending on sub-ethnicity; it is
Current sm
Figure 1: Proportion of people living in New Zealand communities, by deprivation status, who are current smokers,
adapted from NZDep20136
38 BPJ Issue 64
Adapting the ABC to different patient groups
Why does quitting smoking improve
General practitioners are encouraged to Ask about smoking,
mental health?
Briefly advise to quit and offer Cessation support (ABC), to
all patients who smoke, at every consultation.11 Some health
A meta-analysis of 26 studies found consistent evidence
professionals may be reluctant to persistently advise people
that smoking cessation is associated with improvements
to quit smoking due to concerns that their relationship with
in depression, anxiety, stress, quality of life and positive
patients may be damaged. However, it should be remembered
affect.14 This benefit was similar for people in the general
that most people who smoke are open to the idea of quitting;12
population and for those with mental health disorders.14
80% of current smokers report that they would not smoke if they had their life over again.11
The fallacy that smoking improves mental health can be
understood when the neural changes that long-term
"When was the last time you smoked a cigarette?" is a
smoking causes are considered. Over time, smoking
non-judgemental way of enquiring about smoking status in
results in modification to cholinergic pathways in
patients who are known to be smokers.
the brain, resulting in the onset of depressed mood, agitation and anxiety during short-term abstinence from tobacco, as levels of nicotine in the blood drop.14 When
Understand the barriers before you start
a person who has been smoking long-term has another
Understanding why the patient relapsed into smoking
cigarette their depressed mood, agitation and anxiety is
following attempts to quit allows health professionals to
relieved. However, as a person continues to abstain from
provide individual strategies, e.g. encouraging the patient's
smoking the cholinergic pathways in the brain remodel
partner to also take part in the quit attempt if the partner is
and the nicotine withdrawal symptoms of depressed
influencing the patient's smoking status. Having a partner
mood, agitation and anxiety are reduced through
who continues to smoke during pregnancy is said to "almost
abstinence from nicotine. The process whereby people
universally predict" a return to smoking among women who
relieve withdrawal symptoms with a drug, i.e. nicotine,
which then reinforces these symptoms is referred to as a withdrawal cycle and it may also be associated with a
Fear of consequences can encourage smoking
decline in mental health.14
For people whose social life is restricted to family/whanau and neighbours, a fear that quitting smoking can result in being
"left-out" socially is a barrier to quitting.12 Concerns that giving
up smoking will cause illness are also not uncommon, e.g. coughing or chest infections following quitting. Other barriers
The effects of smoking cessation on
to quitting smoking that are frequently reported include: fear
patients with mental health disorders
of weight gain, boredom and the timing of a quit attempt being problematic.12 A patient's individual concerns about
Hydrocarbons and tar-like products in tobacco smoke
quitting need to be addressed when discussing smoking
are known to induce the cytochrome P450 enzyme
CYP1A2.15 When patients taking other medicines that are metabolised by this enzyme stop smoking there
Viewing smoking as a stress-reliever can be a barrier to
may be an initial rise in medicine levels in their blood
as enzymatic activity falls to normal levels. There may
People who smoke often view it as a stress-relieving activity,
be some instances where stopping smoking in a patient
therefore do not want to quit.12, 14 There may also be concern
taking certain antipsychotics (e.g. clozapine, olanzapine,
that quitting smoking will worsen mood in people with a
chlorpromazine, haloperidol) or insulin causes clinically
mental health disorder.14 In fact the opposite is more likely
significant changes in serum concentrations.15 Patients
to be the case: smoking cessation has been shown to have
with insulin-dependent diabetes who stop smoking
beneficial effects on mood disorders, with an effect size equal
should be alert to the symptoms of hypoglycaemia and
to, or larger than, treatment with antidepressants.14 Health
increase their frequency of blood glucose monitoring.16
professionals should acknowledge that a patient's mood may improve in the minutes after smoking a cigarette. However, this is an opportunity to explain to the patient that the reason
BPJ Issue 64 39
they feel better is because they are addicted to nicotine, and
without assessing their readiness to stop smoking. Only
that every puff continues this cycle (see: "Why does quitting
offering cessation support to people with a stated desire to
smoking improve mental health?", previous page). The patient
quit smoking is a missed opportunity for positive change. Also
can then be reassured that al people who break the cycle of
see: "A review of pharmacological smoking cessation aids",
smoking addiction will experience mental health benefits.14
N.B. The doses of antipsychotics used to treat some mental health disorders (and insulin) may need to be adjusted if
A meta-analysis of the effect of cessation support found that
abrupt cessation occurs in a person who is heavily dependent
offers of cessation support by health professionals, e.g. "If you
on cigarettes (see: "The effects of smoking cessation on
would like to quit smoking I can help you do it", motivated
patients with mental health disorders: previous page).
an additional 40 – 60% of patients to stop smoking within six months of the consultation, compared to being advised to quit smoking on medical grounds alone.4 It is important to
From talking to quitting
note that the motivation of patients to stop smoking was not
Motivational interviewing can increase the likelihood that a
assessed before offers of cessation support were made.
patient will attempt to quit smoking and increase the chances of them succeeding.10
Referral to a smoking cessation service is recommended
Quitline is a smoking cessation service which offers phone-
The general techniques of motivational interviewing
based support, six days a week (Monday – Friday 8 am – 9.30
pm, Sunday 10 am – 7.30 pm on 0800 778 778) to all people
1. Expressing empathy
who want to quit smoking. People can self-refer to Quitline or they can be referred by a health professional. Patients can
e.g. "So you've already tried to give up smoking a couple
also be referred electronically if the relevant feature is enabled
of times and now you're wondering if you will ever be
on the practice management system. Txt2Quit support is
available from Quitline directly to mobile phones.
2. Developing the discrepancy between the goal of being
For further information go to: www.quit.org.nz
smokefree and the behaviour of smoking
e.g. "It's great that your health is important to you, but
Aukati Kai Paipa is a free smoking cessation service that
how does smoking fit with that for you?"
delivers face-to-face coaching for Māori from over 30 centres around New Zealand.
3. Rolling with resistance
e.g. "It can be hard to cope when you're worried about
To find your closest provider go to the Aukati Kai Paipa
your mother's health and I realise that smoking is one of
website at: www.aukatikaipaipa.co.nz/contact-us
the ways that you've used to give yourself a break. What other ways do you think you could use? "
Smokefree Communities offers smoking cessation services to people living in the North Shore, Waitakere and Rodney
4. Encouraging self efficacy
areas. Programmes focus on reducing rates of smoking among women who are pregnant and their whanau/family, Asian
e.g. "Last time you didn't think you'd be able to manage
people and their families, and al families with children aged
without smoking at al – and you've actual y gone al week
under 16 years. Smokefree Communities provides support in
with only two cigarettes – what did you do differently this
Chinese, Korean, Burmese and Hindi/Fiji Hindi languages.
time to make that happen?"
To find out more about Asian Smokefree services go to:
A goal of care when consulting with patients who are current
smokers is to negotiate a firm quit date and to agree on "not
one puff" from that point onwards.10
Cessation support is the most important aspect of the
Preventing smoking relapses
ABC approach
Health professionals can discuss strategies with patients to
It is important that cessation support, e.g. referral to smoking
help manage triggers where there is extra pressure to smoke.
cessation service, should be offered to all people who smoke
For example, focus on something that is important to the
40 BPJ Issue 64
patient and incorporate it into a response that they use to decline an offer to smoke, e.g. "No thanks, my daughter has asthma – our home is now smokefree to help her breathing
Incentives to smokefree pregnancies
get better".
Incentive programmes have recently been launched to encourage pregnant women to quit smoking in some
Creating a wave of social support
North Island areas, including Waikato, Counties Manukau
Encourage the person quitting to reach out for assistance
and Northland DHBs. As part of the Waikato programme,
from anyone they know who has previously quit smoking.
vouchers to a total value of $250 are given to Māori or
Peer support for people who are attempting to quit smoking
Pacific women who are up to 28 weeks pregnant, at one,
can take many forms. The rationale is that a person with similar
four, eight and 12 weeks after they have quit smoking.19
life experiences to the person who wants to stop smoking
Vouchers are intended to be spent on items such as
can provide practical tips that fit with their lifestyle. A friend
groceries or petrol; they cannot be exchanged for cash
or family member is also more likely to have regular contact
or spent on cigarettes or alcohol.19 The smokefree status
with the person attempting to quit. Examples of peer support
of the women participating is measured by testing
might be having a coffee or tea together each morning to
exhaled carbon monoxide levels. It was reported that this
discuss any difficulties or temptations, or attending situations
was a positive influence on quit attempts as it provided
together where there may be a strong temptation to smoke,
accountability.20 The Counties Manukau programme
e.g. the pub.
resulted in a 65% quit rate at four weeks and a 60% rate at 12 weeks.20
There is some evidence that peer support may be more
successful when people in deprived communities attempt to quit smoking, compared with people in the general population.17 Some maraes in New Zealand have also run competitions that both challenge people who are quitting smoking to stay smokefree while also supporting each other's quit attempts.
The Quitline Blog is the most popular online smoking cessation
peer support forum operating in New Zealand. People who are attempting to quit smoking can be encouraged to access this forum to receive support at any time of the day or night.
Social networking platforms, e.g. Facebook, can also be used to provide a substitution for social situations where the person has previously found it difficult to resist the temptation to smoke. Social networking is more likely to be used by younger
people who smoke and have regular access to the internet.
The Aukati KaiPaipa Facebook page is available at: www.
Children are a positive and motivating influence
The health-related and financial benefits that the children
of people who smoke gain when their parents quit smoking is a powerful motivating factor.12 In particular, prospective parenthood can provide additional motivation to stop smoking. Having a smokefree pregnancy and then maintaining a smokefree household means that children are less likely to develop middle ear infections, or to have lower respiratory illness, asthma or abnormal lung growth, and have a lower incidence of sudden unexplained death in infancy.11
BPJ Issue 64 41
The cost of smoking just keeps going up
A review of pharmacological
Cost increase is a recognised method for decreasing cigarette consumption. As part of the drive to create a smokefree New
smoking cessation aids
Zealand by 2025, it is government policy that an average
pack of 20 cigarettes will cost more than $20 by 2016, with
Pharmacological aids for smoking cessation can reduce
future price increases beyond this highly likely.18 This policy
nicotine cravings and lessen withdrawal symptoms. An
is supported by the Royal New Zealand College of General
offer of medical assistance may embolden people who have
Practitioners.11
previously attempted to quit smoking without support to try again. Pharmacological aids also reduce the likelihood of a
At a cost of $20, a pack-a-day smoker would be spending
lapse in abstinence becoming a return to long-term smoking.
$140 a week, or more than $7000 per year on cigarettes. The
money that a family/whanau can save by quitting smoking
The important factors to consider when discussing smoking
can, and should, be used to create goals that unite families in
cessation treatment options are the patient's preferences and
their desire to be smokefree. For example, as well as spending
previous experience of smoking cessations aids, the patient's
the extra money on essentials such as clothing, a small weekly
likely adherence to treatment and the possibility of any
treat such as going to the local swimming pool can provide
adverse effects.
an ongoing and tangible incentive to being smokefree. Longer term goals such as saving for a family holiday can also create
family "buy-in" and may help parents remain abstinent from
Nicotine replacement therapy
smoking in the months following their quit date.
The use of NRT approximately doubles the likelihood of a
person being able to quit smoking long-term; one in 14 people who would not otherwise have stopped smoking will do so for
What to do if the patient does have another cigarette?
at least six months following a course of NRT.15 Several studies
If a patient who is attempting to quit reports that they have
suggest that in people who are unmotivated to quit within the
had a brief smoking lapse then it is important that they do not
next month, the use of NRT results in an increased number of
see this as a failure. Support is required to help them avoid
quit attempts and marginally higher rates of abstinence.21 NRT
feelings of guilt and loss of control that can undermine their
may therefore act as a quit catalyst for patients who smoke
quit attempt. Remind patients that many people who quit
and who report that they are not yet ready to stop.21 Offering
experience lapses. Encourage the patient to continue to use
patients who smoke the opportunity to trial different forms of
NRT and any other smoking cessation medicines that have
NRT before they attempt to quit may also improve their choice
been prescribed. Ask the patient to again commit to "not
of NRT and result in better treatment adherence.
one puff" onwards and to ensure that cigarettes, lighters and ashtrays have been discarded.
Most people who are attempting to quit smoking do not use enough NRT.22 Patients who are heavily dependent on cigarettes may gain benefit from increasing the dose of nicotine, e.g. wearing two patches, to replicate the levels of nicotine that reach the brain when they are smoking. Combining NRT products, e.g. using a nicotine patch and nicotine gum, is more effective than using a single NRT product.15 If patients begin to
feel nauseous when using NRT they can be advised to reduce the frequency or dose of the product.22
Subsidised NRT can be prescribed by general practitioners and registered Quit Card Providers. Subsidised supplies of NRT
may also be obtained by general practices using a Practitioner
Supply Order. Pharmacists can supply subsidised NRT that is
prescribed on a normal prescription (maximum quantity 12 weeks) or a Quit Card (maximum quantity 8 weeks) at a cost of
$5; these wil be dispensed in four-week quantities. Pharmacists
are not able to prescribe subsidised NRT unless they are part of a special regional programme, e.g. Canterbury DHB.
42 BPJ Issue 64
Nicotine replacement therapy should be continued for at
is indicated for people who are highly dependent on tobacco,
least eight weeks; the normal treatment course is 12 weeks.23
i.e. smoking within an hour of waking. The gum should be
Patients who feel they are still gaining benefit from treatment
bitten to liberate a peppery flavour. The gum should not be
can continue to use NRT for longer periods.23 If patients wish
chewed continuously as swallowed nicotine can result in
to use NRT as a way of reducing cigarette consumption, prior
gastrointestinal disturbance. It can be placed between the
to quitting, then cigarette use should be reduced to half at six
cheek and gum and chewed again when the taste fades, and
weeks and completely stopped at six months.23
disposed of after 30 minutes.22, 23
In order to determine an appropriate NRT regimen, New
Nicotine lozenges are available in 1 mg and 2 mg formulations.
Zealand guidelines recommend combining the time until the
It is recommended that lozenges be used regularly when
first cigarette with the total number of cigarettes a person
nicotine cravings occur.22 The 2 mg formulation is indicated
smokes each day (Figure 2). The amount of time that passes
for people who are highly dependent on tobacco, i.e. smoking
after waking until a person smokes their first cigarette is a
within an hour of waking.
useful guide when assessing nicotine dependence; New
Zealand guidelines use smoking within an hour of waking
All people who wish to quit smoking can use NRT, including
as a sign of high tobacco dependence,22 smoking within five
people with cardiovascular disease and women who are
minutes of waking is a sign of severe dependence.10
pregnant or breastfeeding, if they would otherwise continue to smoke.22 When discussing the use of NRT with a woman
Nicotine patches are fully subsidised in New Zealand and
who is pregnant or breastfeeding perform a risk assessment
available in 7mg, 14 mg and 21 mg patches. These should be
and consider "Can she quit without NRT?" If not, NRT is safer
pressed in place on dry, clean and hairless skin, and replaced
than smoking. A study involving over 1700 pregnant women
daily.22 Patches may cause some dermal erythema.22 If patients
who used NRT found no significant association between NRT
report disturbed sleep while using nicotine patches then they
use and decreased infant birth weight.24 Pregnant women who
should be removed at night.
are using nicotine patches should remove them overnight.22
Adolescents aged 12 years or over can also be prescribed
Nicotine gum is available in 2 mg and 4 mg formulations. It is
NRT,22 however, the use of NRT alone is unlikely to address
recommended that nicotine gum be used regularly by people
the reasons why an adolescent has begun, and continues to
who are attempting to quit smoking.22 The 4 mg formulation
Smokes after one
Smokes within one
hour of waking
hour of waking
Smokes fewer
Smokes fewer
more a day
more a day
either 2 mg gum or
either 2 mg gum or
either 4 mg gum or
Figure 2: Nicotine dependence assessment algorithm for determining an appropriate NRT treatment regimen, adapted
from "Guide to prescribing nicotine replacement therapy (NRT)"22
BPJ Issue 64 43
Table 1: Comparison of smoking cessation medicines that are subsidised in New Zealand23
Funding status* Fully subsidised
Fully subsidised with Special
Authority approval for people
who have tried previously to quit smoking with other medicines†
Efficacy Almost doubles a patient's
Almost doubles a patient's
Approximately triples a
chances of quitting smoking
chances of quitting smoking
patient's chances of quitting
Mechanism of action Atypical antidepressant
Tricyclic antidepressant
Stimulates nicotine receptors
which aids smoking cessation
which aids smoking cessation
less than nicotine, i.e. is a
independently of its
independently of its
partial agonist, thereby
antidepressant action15
antidepressant action15
reducing cravings, and, at the same time, reduces the rewarding sensation of smoking, i.e. antagonist effect.10
Contraindications Lowers seizure threshold
Should not be taken by
None, however, patients and
and should not be taken by
patients: who are acutely
their family/whanau should
patients with acute alcohol or
recovering from a myocardial
be vigilant for changes in
benzodiazepine withdrawal,
infarction, with arrhythmias,
behaviour, thinking or mood,
CNS tumour, eating disorders,
during manic phases of bipolar in particular depression and
bipolar disorder, use of
disorder, with acute porphyria,
suicidal ideation. If this occurs
monoamine oxidase inhibitors
who are breast feeding, or
cease taking the medicine
(MAOI) in the last 14 days, and
who have used a MAOI in the
and seek medical advice
in patients with severe hepatic
Adverse effects In general, bupropion is
Has the potential to cause
Nausea may occur in
considered to be a safer
more harm than bupropion
approximately one-third of
medicine than nortriptyline.
and can be fatal in overdose.15
patients, but this is generally
One in a thousand patients
Adverse effects include: dry
mild and will only be
are expected to have a seizure
mouth, constipation, nausea,
intolerable in a few patients.10
over the course of treatment.25
sedation (which can affect
Use with caution in patients
driving ability) and headaches.
taking antipsychotics due to
Advise patients to avoid
increased seizure risk. Skilled
alcohol as sedation may be
tasks, such as driving, may be
Women who are Avoid during pregnancy
Should only be taken during
Avoid during pregnancy
pregnancy when the benefits outweigh the risks
44 BPJ Issue 64
Patients with mental May cause levels of citalopram
In general, nortriptyline
See contraindications
health issues to be raised in some patients
should be used with caution in patients thought to be at an increased risk of suicide, or who have a history of psychosis.
Levels of nortriptyline can be increased by two to four-fold, or occasionally more, by the concurrent use of fluoxetine; in this situation nortriptyline dose reductions of 75% have been suggested.
Dosing Initiate one to two weeks
Initiate ten to 28 days before
Initiate one to two weeks
before quit date with one 150
the agreed quit date with
before the quit date, at 500
mg bupropion tablet, daily, for
nortriptyline 25 mg, daily,
micrograms varenicline, daily,
three days, then 150 mg, twice
gradually increase over ten
for three days, increased to
daily. The maximum single
days to five weeks to 75 – 100
500 micrograms varenicline,
dose is 150 mg bupropion,
mg nortriptyline daily, for up
twice daily, for four days, then
and the maximum daily dose is to three to six months. The
1 mg twice daily for 11 weeks.
300 mg bupropion. Treatment
dose should be slowly tapered
The 1 mg dose can be reduced
is usually for seven weeks. For
while treatment is withdrawn.
to 500 micrograms if it is not
people with risk factors for
tolerated. This course can be
seizures or in elderly patients
repeated to reduce the risk of
the maximum daily dose is 150
mg bupropion.
* Subsidy status correct at the time of printing. Check the New Zealand Formulary for latest information.
† Varenicline is fully subsidised with Special Authority approval for people who have tried previously to quit smoking with other medicines and have not
used varenicline in the preceding 12 months. In order to qualify for subsidy patients must:
Indicate that they are ready to cease smoking; and Have enrolled, or about to enrol in a smoking cessation programme that includes prescriber or nurse monitoring; and Have trialled and failed to quit smoking previously using bupropion or nortriptyline; or tried but failed to quit smoking on at least two separate
occasions using NRT, with at least one of these attempts including the patient receiving comprehensive advice on the use of NRT; and
Not have used subsidised varenicline in the last 12 months; and Agree not to use varenicline in combination with other pharmacological cessation medicines; and Not be pregnant; and Not be prescribed more than three months funded varenicline
BPJ Issue 64 45
Nicotine inhalators (15 mg nicotine cartridges) and
nicotine mouth spray (1 mg nicotine per dose) are available
Electronic-cigarettes – the jury is still out
as unsubsidised NRT products. Nicotine inhalators can be puffed on for 20 minutes every hour, and the cartridge
Electronic-cigarettes are a topic in smoking cessation
replaced after three hours.22 One cigarette puff is equivalent
that is evolving rapidly, both in terms of device design
to approximately ten inhalator puffs.22 Nicotine mouth sprays
and evidence of effectiveness. The devices electronically
are also recommended for regular use, or for when cravings
vaporise a solution made up of propylene glycol and/
occur.22 After priming the pump, direct one spray to the inside
or glycerol, nicotine and flavourings, that users inhale
of each cheek. Advise patients to resist swallowing for several
rather than burning tobacco leaves.26 The solution is held
seconds after application to achieve best results.22
in cartridges that are inserted into the device.26 These devices are different to nicotine inhalators.
For further information see the "Guide to prescribing
nicotine replacement therapy (NRT)" available from:
The body of research on electronic-cigarettes is small, but
growing quickly, and opinion is divided as to the potential harms or benefits to personal or public health.27 Currently,
Medicines to aid smoking cessation
no electronic cigarette products have been approved under the Medicines Act for sale or supply in New Zealand
Medicines for smoking cessation should be prescribed in
and therefore it is illegal to sell an electronic-cigarette
combination with behavioural support, e.g. Quitline, to
that contains nicotine.26 It is also illegal for electronic-
improve their effectiveness.10 Table 1 (previous page) provides
cigarettes, with or without nicotine, to be sold as
a comparison of smoking cessation medicines subsidised
smoking cessation aids, or for an electronic-cigarette that
in New Zealand. In general smoking cessation medicines
resembles a tobacco product to be sold to a person under
should not be used by women who are pregnant because
the age of 18 years.26 However, electronic-cigarettes are
the potential risk to foetal development cannot be balanced
available on international websites as smoking cessation
against the known benefits of smoking cessation.15 Some
aids and many people who smoke are interested in using
smoking cessation medicines may not be appropriate for
them for that purpose.
patients with a history of mental disorders.
Electronic-cigarettes are considered by experts to be less harmful than conventional cigarettes, however, short-term adverse effects have been attributed to exposure to propylene glycol including eye and respiratory irritation.28
The aerosol that electronic-cigarettes produce contains
a number of cytotoxic and carcinogenic chemicals that may pose long-terms risks to women who are pregnant.28
These compounds are present at levels one to two orders
of magnitude lower than is present in tobacco smoke, but at higher levels than is found in nicotine inhalers.28
Both the Ministry of Health and WHO recommend that people who smoke should be encouraged to quit using a combination of approved NRT products, i.e. patches, lozenges and gum.26 The Ministry of Health intends to assess new evidence as it arises regarding the safety and appropriateness of the use of electronic-cigarettes as smoking cessation aids.
46 BPJ Issue 64
Māori people to quit smoking. Quitline, 2014. Available from: www.
ACKNOWLEDGEMENT: Thank you to Dr Brent
Caldwell, Senior Research Fellow, Department of
2014website.pdf (Accessed Oct, 2014).
Medicine, University of Otago, Wellington, Dr Marewa
13. Mullen PD. How can more smoking suspension during pregnancy
Glover, Director of the Centre for Tobacco Control
become lifelong abstinence? Lessons learned about predictors,
Research, University of Auckland and Dr Hayden
interventions, and gaps in our accumulated knowledge. Nicotine Tob Res 2004;6 Suppl 2:S217–38.
McRobbie, Senior Lecturer, School of Public Health
and Psychosocial Studies, Auckland University of
14. Taylor G, McNeill A, Girling A, et al. Change in mental health after
smoking cessation: systematic review and meta-analysis. BMJ
Technology, Consultant, Inspiring Limited for expert
guidance in developing this article.
15. Ministry of Health (MOH). New Zealand smoking cessation guidelines.
MOH, 2007. Available from: www.health.govt.nz (Accessed Oct,
16. UK Medicines Information. Which medicines need dose adjustment
when a patient stops smoking? 2012. Available from: www.evidence.
1. Ministry of Health. New Zealand Health Survey: Annual update of key
nhs.uk (Accessed Oct, 2014).
findings 2012/13. Wellington: Ministry of Health 2013. Available from: www.health.govt.nz/publication/new-zealand-health-survey-annual-
17. Ford P, Clifford A, Gussy K, et al. A systematic review of peer-support
update-key-findings-2012-13 (Accessed Oct, 2014).
programs for smoking cessation in disadvantaged groups. Int J Environ Res Public Health 2013;10:5507–22.
2. Borland R, Partos TR, Yong H-H, et al. How much unsuccessful
quitting activity is going on among adult smokers? Data from the
18. Smokefree Coalition. Quitting tobacco would reduce poverty: media
International Tobacco Control Four Country cohort survey. Addiction
release. 2013. Available from: www.sfc.org.nz/media/131211-quitting-
tobacco-would-reduce-poverty.pdf (Accessed Oct, 2014).
3. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term
19. Waikato DHB. Waikato picks up incentive programme for smokefree
abstinence among untreated smokers. Addiction 2004;99(1):29–38.
pregnancies. 2014. Available from: www.waikatodhb.health.nz (Accessed Oct, 2014).
4. Aveyard P, Begh R, Parsons A, et al. Brief opportunistic smoking
cessation interventions: a systematic review and meta-analysis
20. Auahi Kore. Counties Manukau smokefree pregnancy incentives
to compare advice to quit and offer of assistance. Addiction
pilot. Available from: http://smokefree.org.nz/counties-manukau-
smokefree-pregnancy-incentives-pilot (Accessed Oct, 2014).
5. Morton S, Atatoa C, Bandara D, et al. Growing up in New Zealand: A
21. Carpenter MJ, Jardin BF, Burris JL, et al. Clinical strategies to enhance
longitudinal study of New Zealand children and their families. Report
the efficacy of nicotine replacement therapy for smoking cessation:
1: Before we are born. 2010. Available from: https://researchspace.
a review of the literature. Drugs 2013;73:407–26.
auckland.ac.nz/handle/2292/6120 (Accessed Oct, 2014).
22. Ministry of Health (MOH). Guide to prescribing nicotine replacement
6. Atkinson J, Salmond C, Crampton P. NZDep 2013 Index of Deprivation.
therapy. MOH, 2014. Available from: www.health.govt.nz (Accessed
2014. Available from: www.otago.ac.nz/wellington/otago069936.pdf
(Accessed Oct, 2014).
23. New Zealand Formulary (NZF). NZF v28. 2014. Available from: www.
7. ASH: Action on smoking and health. Māori smoking: fact sheet. ASH,
nzf.org.nz (Accessed Oct, 2014).
2014. Available from: www.ash.org.nz/wp-content/uploads/2014/01/
24. Lassen TH, Madsen M, Skovgaard LT, et al. Maternal use of nicotine
Māori_smoking_ASH_NZ_factsheet.pdf (Accessed Oct, 2014).
replacement therapy during pregnancy and offspring birthweight:
8. Quitline. Quitline client demographics - quarterly reports April - June
a study within the Danish National Birth Cohort. Paediatr Perinat
2014. Available from: www.quit.org.nz/68/helping-others-quit/
research/quitline (Accessed Oct, 2014).
25. Hughes JR, Stead LF, Hartmann-Boyce J, et al. Antidepressants for
9. ASH: Action on smoking and health. Pacific smoking: factsheet. ASH,
smoking cessation. Cochrane Database Syst Rev 2014;1:CD000031.
2014. Available from: www.ash.org.nz/wp-content/uploads/2013/01/
26. Ministry of Health (MOH). Electronic Nicotine Delivery Systems (ENDS),
including E-cigarettes. MOH, 2014. Available from: www.health.govt.
nz (Accessed Oct, 2014).
10. Zwar NA, Mendelsohn CP, Richmond RL. Supporting smoking cessation.
27. McNeil A, Etter J-F, Farsalinos K, et al. A critique of a WHO-commissioned
BMJ 2014;348:f7535.
report and associated article on electronic cigarettes. Addiction
11. The Royal New Zealand College of General Practitioners (RNZCGP).
2014;[Epub ahead of print].
Tobacco position statement. RNZCGP, 2013. Available from: www.
28. WHO Famework Convention on Tobacco Control. Electronic nicotine
rnzcgp.org.nz/position-statements-2 (Accessed Oct, 2014).
delivery systems: WHO, 2014. Available from: http://apps.who.int/gb/
12. Research to support targeted smoking cessation: Insights on how
fctc/PDF/cop6/FCTC_COP6_10-en.pdf?ua=1 (Accessed Oct, 2014).
to encourage people living in high deprivation communities and/or
BPJ Issue 64 47
Source: http://www.smokefreenurses.org.nz/site/nursesaotearoa/BPJ64-smoking-cessation.pdf
Elementalwatson "la" revista ………………. Revista cuatrimestral de divulgación "En el conocimiento y la cultura no Año 4, número 11 sólo hay esfuerzo sino también placer. Llega un punto donde estudiar, o investigar, o Universidad de Buenos Aires Ciclo Básico Común (CBC) aprender, ya no es un esfuerzo y es puro
Gabi Schwaiger-Ludescher Musiktherapie mit einer chronisch schizophrenen Frau – Beispiel einer Auseinandersetzung mit dem Modell der Affektlogik nach Luc Ciompi Luc Ciompis Affektlogik, erstmals herausgegeben 1982, wählte ich zur Grundlage meiner Diplomarbeit, wobei es mir ein Anliegen war, seine Theorie der Entstehung „Schizophrener Verrücktheit" sowie die daraus resultierenden Verständnis- und Behandlungskonsequenzen im Zusammenhang mit musiktherapeutischem Tun zu betrachten. Ich werde in einem ersten Schritt den Begriff Affektlogik sowie das dreiphasige Modell der Schizophrenen Verrücktheit vorstellen. Anschließend beleuchte ich die sich daraus ergebenden